ADAMTS1 alters blood vessel morphology and TSP1 levels in LNCaP and LNCaP-19 prostate tumors

BACKGROUND: Decreased expression of the angiogenesis inhibitor ADAMTS1 (ADAM metallopeptidase with thrombospondin type 1 motif, 1) has previously been reported during prostate cancer progression. The aim of this study was to investigate the function of ADAMTS1 in prostate tumors. METHODS: ADAMTS1 wa...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Gustavsson, Heléne, Tešan, Tajana, Jennbacken, Karin, Kuno, Kouji, Damber, Jan-Erik, Welén, Karin
Formato: Artigo
Lenguaje:Inglês
Publicado: BioMed Central 2010
Materias:
Research Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC2894797/
https://ncbi.nlm.nih.gov/pubmed/20546609
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-10-288
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares